LYB vs STOK · P/E 21, rev $16.37B vs rev $15.6M
LyondellBasell Industries NV (LYB) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. STOK currently screens at market cap $1.88B.
Not investment advice. Open the LYB and STOK stock pages for the full models.
Not investment advice.